BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32110228)

  • 21. Paraneoplastic neurological syndromes.
    Graus F; Dalmau J
    Curr Opin Neurol; 2012 Dec; 25(6):795-801. PubMed ID: 23041955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurological syndromes, encephalitis].
    Yamamoto T; Tsuji S
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis.
    Monstad SE; Nøstbakken JK; Vedeler CA
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):241-2. PubMed ID: 19151024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
    Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
    J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitfalls in the detection of CV2 (CRMP5) antibodies.
    Sabater L; Saiz A; Dalmau J; Graus F
    J Neuroimmunol; 2016 Jan; 290():80-3. PubMed ID: 26711575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of paraneoplastic myelopathy associated with anti-CV2/CRMP5 antibodies with small-cell lung cancer].
    Sato C; Kano T; Yabe I; Sasaki H
    Rinsho Shinkeigaku; 2020 Aug; 60(8):560-564. PubMed ID: 32641628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Three patients with a paraneoplastic neurological syndrome: the significance of paraneoplastic antibodies].
    Smitt PA; Polman SK; de Beukelaar JW; Enting RH; van den Bent MJ; Bromberg JE; Kros JM; Hooijkaas H
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):874-80. PubMed ID: 17472120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Limbic encephalitis with antibodies against intracellular antigens].
    Morita A; Kamei S
    Brain Nerve; 2010 Apr; 62(4):347-55. PubMed ID: 20420174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
    Yamamoto T; Tsuji S
    Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients.
    Gultekin SH; Rosenfeld MR; Voltz R; Eichen J; Posner JB; Dalmau J
    Brain; 2000 Jul; 123 ( Pt 7)():1481-94. PubMed ID: 10869059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paraneoplastic epilepsy.
    Serafini A; Lukas RV; VanHaerents S; Warnke P; Tao JX; Rose S; Wu S
    Epilepsy Behav; 2016 Aug; 61():51-58. PubMed ID: 27304613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting disability and mortality in CV2/CRMP5-IgG associated paraneoplastic neurologic disorders.
    Uysal SP; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Conway DS; Ontaneda D; Morren JA; Kunchok A
    Ann Clin Transl Neurol; 2024 Mar; 11(3):710-718. PubMed ID: 38251800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A paraneoplastic syndrome misdiagnosed as ALS: What are the red flags? A case report and review of the literature.
    Tolkovsky A; Kipervasser S; Fainmesser Y; Alcalay Y; Gadoth A
    J Neuroimmunol; 2021 Sep; 358():577635. PubMed ID: 34217018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Case of Paraneoplastic Limbic Encephalitis in a Patient with Invasive Thymoma with Anti-Glutamate Receptor Antibody-Positive Cerebrospinal Fluid: A Case Report.
    Inoue T; Kanno R; Moriya A; Nakamura K; Watanabe Y; Matsumura Y; Suzuki H
    Ann Thorac Cardiovasc Surg; 2018 Aug; 24(4):200-204. PubMed ID: 29269707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amyotrophic lateral sclerosis and anti-CV2 antibodies. Paraneoplastic association?].
    García Martín G; Perez Errazquin F; Chamorro Muñoz M; Romero Acebal M
    Neurologia; 2007; 22(6):406-9. PubMed ID: 17610172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies.
    Ducray F; Roos-Weil R; Garcia PY; Slesari J; Heinzlef O; Chatelain D; Toussaint P; Roullet E; Honnorat J
    J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):325-7. PubMed ID: 17308295
    [No Abstract]   [Full Text] [Related]  

  • 38. Four kinds of antibody positive paraneoplastic limbic encephalitis: A rare case report.
    Huang P; Xu M
    World J Clin Cases; 2023 Mar; 11(7):1586-1592. PubMed ID: 36926412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
    Younes-Mhenni S; Janier MF; Cinotti L; Antoine JC; Tronc F; Cottin V; Ternamian PJ; Trouillas P; Honnorat J
    Brain; 2004 Oct; 127(Pt 10):2331-8. PubMed ID: 15361417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRMP5 antibodies in patients with small-cell lung cancer or thymoma.
    Monstad SE; Drivsholm L; Skeie GO; Aarseth JH; Vedeler CA
    Cancer Immunol Immunother; 2008 Feb; 57(2):227-32. PubMed ID: 17657489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.